MDaaS, co-founded in 2017 by Oluwasoga Oni (CEO), Opeyemi Ologun (Country Manager), and Genevieve Oni (CFO), offers several health services at its diagnostic centres, including imaging (digital x-ray and ultrasound), cardiac services (ECG and echo), and other lab services such as chemistry analysis, immunoassay, and haematology.
Given how elusive quality healthcare is in Nigeria, people tend to ignore prevention and wait until they need to treat illnesses. Consequently, many potentially fatal diseases, particularly those that are not contagious, go undetected until it is too late.
However, MDaaS is attempting to address this crippling healthcare challenge by increasing access to diagnostics and preventive care through the use of cutting-edge technology. The company believes the new investment will help it further its mission.
Patients can access these services through the company’s SentinelX app, a personalised care programme that allows them to pay a yearly service fee to access a doctor.
SentinelX, initially designed to serve individuals, has since been redesigned to focus on businesses.
Per CEO Oni, “While SentinelX didn’t perform as well as a B2C product, it has been highly successful as a B2B product.”
Read Also: Canal+ Increases the Offer for MultiChoice to $2.7 Billion
He stated that the company now focuses on serving corporations by providing annual employee screenings, pre-employment screenings, and government-mandated screenings.
The CEO noted that these business-centred services are now an essential source of revenue for the company, in addition to individual customers who still visit its centres for screenings.
What MDaaS is Into
MDaaS, which builds and operates tech-enabled diagnostic clinics in multiple locations. They said it will use the new funding to scale BeaconOS, its proprietary technology platform that debuted in 2023.
BeaconOS is a company-owned technology platform that digitises patient records, streamlines appointment scheduling and optimises diagnostic workflows. This will improve healthcare access, efficiency, and outcomes for millions of underserved Nigerians.
Currently, the healthcare company operates 17 diagnostic centres across 10 states, serving over 275,000 patients, most of whom are female. The company intends to build an additional 23 diagnostic centres.
MDaaS operates in 25 Nigerian cities and works with over 1,300 clinical partners. 34 Health Maintenance Organisations (HMOs) and approximately 1,000 organisations. Including hospitals, pharmacies, health tech startups, and corporate partners.
Background Story About MDaaS
MDaaS Global was founded by three MIT alumni Oluwasoga Oni (CEO), Opeyemi Ologun (Country Manager), and Genevieve Oni (CFO). They have built a supply chain to get refurbished medical equipment into low-income African communities. Its clinic in Nigeria has diagnosed over 10,000 patients since they launched.
Operating outside of the wealthier and well-resourced city center. The company’s clinic offers affordable diagnostic services, including ultrasounds, X-rays, malaria tests, and other lab services. These were previously inaccessible to many families in the area.
MDaaS has accomplished this by building a supply chain that gets refurbished medical equipment into the African communities that need them most. And by leveraging technology to streamline clinic operations.
Frequently Asked Questions
Who is the founder of MDaaS Global?
Oluwasoga Oni is the CEO and Founder of MDaaS. He is the former software engineer II at EMC. Oluwasoga is a graduate of Massachusetts Institute of Technology.
What is medical device as a service?
Medical Device-as-a-Service (medical DaaS) is an emerging business model that allows consumers to access electronic devices and their associated software through a monthly subscription offered by the vendor.
